Clinical Trial Update: US Inhaled Insulin Therapeutic Choice Questionnaire Study [Phase 3]

View source ↗

Summary

Pfizer conducted a Phase 3 trial (therapeutic-choice questionnaire) evaluating inhaled insulin for Type 2 diabetes; the study is reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Exubera (insulin inhalation powder)

Snippet

Sponsor: Pfizer | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED